Hematology-American Society of Hematology Education Program

Papers
(The H4-Index of Hematology-American Society of Hematology Education Program is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Relapsed disease: off-the-shelf immunotherapies vs customized engineered products57
Clots in unusual places: lots of stress, limited data, critical decisions54
The range of haploidentical transplant protocols in sickle cell disease: all haplos are not created equally49
Acute GVHD: think before you treat34
Provoked vs minimally provoked vs unprovoked VTE: does it matter?33
How do we optimally utilize factor concentrates in persons with hemophilia?31
Thrombocytopenia in pregnancy31
Evidence-Based Minireview: How to utilize new therapies for sickle cell disease29
Recognizing, defining, and managing CAR-T hematologic toxicities27
Optimal approach to T-cell ALL25
The future paradigm of HMA + VEN or targeted inhibitor approaches: sequencing or triplet combinations in AML therapy24
Should older patients with low weight and CKD receive full-dose DOACs for treatment of acute proximal DVT?24
When should gene therapy be considered for transfusion-dependent β-thalassemia patients?23
What factors guide treatment selection in mycosis fungoides and Sezary syndrome?22
Diagnosis and therapeutic decision-making for the neutropenic patient21
Mastocytosis demystified21
Hematopoietic cell transplantation for sickle cell disease: updates and future directions21
Controversies in the management of early-stage Hodgkin lymphoma21
Evidence-Based Minireview: Strategies to manage a severely HLA-alloimmunized patient with refractory thrombocytopenia20
0.2565860748291